Implementation Challenges and Opportunities Related to HPV Vaccination Quality Improvement in Primary Care Clinics in a Rural State
- PMID: 31102115
- PMCID: PMC6934039
- DOI: 10.1007/s10900-019-00676-z
Implementation Challenges and Opportunities Related to HPV Vaccination Quality Improvement in Primary Care Clinics in a Rural State
Abstract
Efforts to understand low human papillomavirus vaccine coverage led us to explore quality improvement (QI) decision-making programs and processes to increase vaccine uptake. These QI programs often include interventions recommended by the AFIX (Assessment Feedback Incentives eXchange) Program that supports Vaccines for Children (VFC) clinics. However, little is known about decision-making around intervention selection or extent of implementation. In collaboration with the state public health department in the rural Midwestern, investigators developed a survey to explore vaccine-related QI in VFC clinics. The survey was distributed via email to all VFC clinics (n = 605); results presented are from the primary care clinics (n = 115). Respondents (VFC liaisons) reported decisions about vaccine QI were made by multiple actors within their own clinics (45.1%), by a clinic manager in charge of multiple clinics (33.0%) and/or at a centralized administrative office (35.2%). Additionally, the majority of respondents considered external actors, like insurance companies (52.7%) or Medicaid/Medicare (50.5%), important to the decision-making process. Most commonly implemented interventions focused on provider knowledge and patient education. Least commonly implemented interventions required systematic changes, such as reminder/recall and follow-up after missed appointments. This preliminary research indicates there are multiple points of decision-making within clinics and health care systems, and therefore change agents at all points need to be involved. The most commonly implemented interventions focus on providers and patients, with an emphasis on education. Interventions requiring system-level changes and use of electronic health records are less common and more attention should be directed towards such interventions.
Keywords: Evidence-based interventions; Papillomavirus vaccines; Primary health care; Quality improvement.
Conflict of interest statement
Similar articles
-
Primary care team- and clinic level factors affecting HPV vaccine uptake.Vaccine. 2017 Aug 16;35(35 Pt B):4540-4547. doi: 10.1016/j.vaccine.2017.07.028. Epub 2017 Jul 20. Vaccine. 2017. PMID: 28736202
-
Improving HPV vaccine delivery at school-based health centers.Hum Vaccin Immunother. 2019;15(7-8):1870-1877. doi: 10.1080/21645515.2019.1578596. Epub 2019 Mar 15. Hum Vaccin Immunother. 2019. PMID: 30735468 Free PMC article.
-
Florida physicians' reported use of AFIX-based strategies for human papillomavirus vaccination.Prev Med. 2018 Nov;116:143-149. doi: 10.1016/j.ypmed.2018.09.004. Epub 2018 Sep 13. Prev Med. 2018. PMID: 30219689 Free PMC article.
-
HPV vaccination: Population approaches for improving rates.Hum Vaccin Immunother. 2016 Jun 2;12(6):1589-93. doi: 10.1080/21645515.2016.1139253. Epub 2016 Feb 18. Hum Vaccin Immunother. 2016. PMID: 26890685 Free PMC article. Review.
-
Human papillomavirus vaccine introduction--the first five years.Vaccine. 2012 Nov 20;30 Suppl 5:F139-48. doi: 10.1016/j.vaccine.2012.05.039. Vaccine. 2012. PMID: 23199957 Review.
Cited by
-
Human Papillomavirus Vaccination Knowledge, Barriers, and Recommendations Among Healthcare Provider Groups in the Western United States.J Cancer Educ. 2022 Dec;37(6):1816-1823. doi: 10.1007/s13187-021-02047-6. Epub 2021 Jul 8. J Cancer Educ. 2022. PMID: 34236651 Free PMC article.
-
Partnering with healthcare systems to improve HPV vaccination:The perspective of immunization program managers.Hum Vaccin Immunother. 2021 Dec 2;17(12):5402-5406. doi: 10.1080/21645515.2021.1993041. Epub 2021 Oct 29. Hum Vaccin Immunother. 2021. PMID: 34715005 Free PMC article.
-
Influences on HPV vaccination across levels of the social ecological model: perspectives from state level stakeholders.Hum Vaccin Immunother. 2021 Apr 3;17(4):1006-1013. doi: 10.1080/21645515.2020.1839290. Epub 2020 Dec 17. Hum Vaccin Immunother. 2021. PMID: 33327850 Free PMC article.
-
Implementation of quality improvement coaching versus physician communication training for improving human papillomavirus vaccination in primary care: a randomized implementation trial.Transl Behav Med. 2022 Jan 18;12(1):ibab071. doi: 10.1093/tbm/ibab071. Transl Behav Med. 2022. PMID: 34244807 Free PMC article. Clinical Trial.
-
Human Papillomavirus Immunization in Rural Primary Care.Am J Prev Med. 2020 Sep;59(3):377-385. doi: 10.1016/j.amepre.2020.03.018. Epub 2020 Jun 27. Am J Prev Med. 2020. PMID: 32605866 Free PMC article.
References
-
- Centers for Disease Control and Prevention. (2018). HPV and cancer. Retrieved August 29, from https://www.cdc.gov/cancer/hpv/statistics/index.htm/.
-
- Kahn JA, Widdice LE, Ding L, Huang B, Brown DR, Franco EL, et al. (2016). Substantial decline in vaccine-type Human Papillomavirus (HPV) among vaccinated young women during the first 8 years after HPV vaccine introduction in a community. Clinical Infectious Disease, 63(10), 1281–1287. - PMC - PubMed
-
- US Department of Health and Human Services, Office of Disease Prevention and Health Promotion. (2019). Immunization and infectious diseases: Objectives. Retrieved April 1, from https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-....
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical